英文名稱 |
中文名稱 |
CAS號(hào) |
操作 |
Posaconazole iMpurity 4 |
泊沙康唑雜質(zhì)4 |
|
詳細(xì)
|
Pitavastatin Impurity 4 ;(3R,5S)-5-(3-(2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)oxiran-2-yl)-3,5-dihydroxypentanoic acid |
匹伐他汀雜質(zhì)4 |
|
詳細(xì)
|
Posaconazole iMpurity 27 |
泊沙康唑雜質(zhì)27 |
|
詳細(xì)
|
Nintedanib Impurity N;(Z)-ethyl 3-(((4-((methyl(3-(4-methylpiperazin-1-yl)-2-oxopropyl)amino)methyl)phenyl)amino)(phenyl)methylene)-2-oxoindoline-6-carboxylate |
尼達(dá)尼布雜質(zhì)N |
|
詳細(xì)
|
Riluzole Impurity 3 |
N-羥基利魯唑 |
179070-90-7 |
詳細(xì)
|
N-Octyl-Nortadalafil |
他達(dá)拉非雜質(zhì) |
1173706-35-8 |
詳細(xì)
|
N-phenylpropenyl Tadalafil |
他達(dá)拉非雜質(zhì) |
2064212-00-4 |
詳細(xì)
|
Pivastatin 72 |
匹伐他汀雜質(zhì)23 |
1467166-39-7 |
詳細(xì)
|
Olmesartan Medoxomil Impurity 21;5-(4'-(dibromomethyl)-[1,1'-biphenyl]-2-yl)-1-trityl-1H-tetrazole |
奧美沙坦酯雜質(zhì)21 |
|
詳細(xì)
|
|
托西酸舒他西林雜質(zhì) |
69-53-4 |
詳細(xì)
|
Nintedanib impurity A |
尼達(dá)尼布雜質(zhì)A |
894783-71-2 |
詳細(xì)
|
Posaconazole iMpurity 8 |
泊沙康唑雜質(zhì)8 |
|
詳細(xì)
|
Obeticholic Acid impurity D |
奧貝膽酸雜質(zhì) D |
|
詳細(xì)
|
Olmesartan Medoxomil Impurity 26 |
奧美沙坦酯雜質(zhì)26 |
144690-04-0 |
詳細(xì)
|
Rebabide Impurity 5 |
瑞巴匹特雜質(zhì)2 |
94670-39-0 |
詳細(xì)
|
Pitavastatin IMpurity 11 |
匹伐他汀雜質(zhì)11 |
|
詳細(xì)
|
Parecoxib Impurity 14 |
帕瑞昔布雜質(zhì)14 |
|
詳細(xì)
|
Pitavastatin IMpurity 20 |
匹伐他汀雜質(zhì)20 |
|
詳細(xì)
|
Nintedanib Impurity M;3-amino-4-(carboxymethyl)benzoic acid |
尼達(dá)尼布雜質(zhì)M |
|
詳細(xì)
|
Pitavastatin IMpurity 24 |
匹伐他汀雜質(zhì)24 |
|
詳細(xì)
|
Nidanib Impurities 61 |
尼達(dá)尼布雜質(zhì)E |
262368-30-9 |
詳細(xì)
|
Posaconazole iMpurity 5 |
泊沙康唑雜質(zhì)5 |
|
詳細(xì)
|
Intedanib Impurity D |
尼達(dá)尼布雜質(zhì)D |
|
詳細(xì)
|
(R)-4-((3R,5S,6R,7S,8S,9S,10S,13R,14S,17R) |
奧貝膽酸雜質(zhì)A |
|
詳細(xì)
|
Pitavastatin Impurity 5 |
匹伐他汀雜質(zhì)5 |
|
詳細(xì)
|
phenyl (4-(4-(4-hydroxyphenyl) |
泊沙康唑雜質(zhì)29 |
|
詳細(xì)
|
Nintedanib Impurity O |
尼達(dá)尼布雜質(zhì)O |
|
詳細(xì)
|
Olmesartan Medoxomil Ethyl Methyl Analog |
|
1378863-74-1 |
詳細(xì)
|
RaMelteon iMpurity C |
雷美替胺雜質(zhì)C |
|
詳細(xì)
|
Posaconazole Impurity 91 |
泊沙康唑雜質(zhì)91 |
1887197-42-3 |
詳細(xì)
|
Obeticholic Acid impurity H |
奧貝膽酸雜質(zhì)H |
|
詳細(xì)
|
Palbociclib Impurity 47 |
帕布昔利布雜質(zhì)9 |
2204368-66-9 |
詳細(xì)
|
Olmesartan Medoxomil Impurity 1 |
|
1392475-91-0 |
詳細(xì)
|
Posaconazole iMpurity 13 |
泊沙康唑雜質(zhì)13 |
|
詳細(xì)
|
Ezetimibe (SSR)-Isomer |
泊沙康唑雜質(zhì)25 |
1042398-26-4 |
詳細(xì)
|
Olmesartan Medoxomil Impurity 22 |
奧美沙坦酯雜質(zhì)22 |
|
詳細(xì)
|
Parecoxib Impurity 18 |
帕瑞昔布雜質(zhì)18 |
|
詳細(xì)
|
(3S,5R,2R,3S)-posaconazole |
泊沙康唑雜質(zhì)18 |
213381-06-7 |
詳細(xì)
|
Olmesartan Medoxomil Impurity 19 |
奧美沙坦酯雜質(zhì)19 |
|
詳細(xì)
|
Olmesartan Medoxomil Impurity X |
奧美沙坦酯雜質(zhì)X |
|
詳細(xì)
|
Rebamipide |
瑞巴派特雜質(zhì) |
90098-04-7 |
詳細(xì)
|
Fudosteine Impurity 3 |
福多司坦雜質(zhì) |
1023971-15-4 |
詳細(xì)
|
Rebamipide Impurity 3 |
瑞巴派特雜質(zhì)3 |
100342-53-8 |
詳細(xì)
|
Posaconazole iMpurity 6 |
泊沙康唑雜質(zhì)6 |
|
詳細(xì)
|
Palbociclib Impurity 31 |
帕布昔利布雜質(zhì)35 |
827022-35-5 |
詳細(xì)
|
Intedanib Impurity C |
尼達(dá)尼布雜質(zhì)C |
|
詳細(xì)
|
Obeticholic Acid impurity B |
奧貝膽酸雜質(zhì)B |
|
詳細(xì)
|
Intedanib Impurity J |
尼達(dá)尼布雜質(zhì)J |
|
詳細(xì)
|
Pitavastatin IMpurity 38 |
匹伐他汀雜質(zhì)38 |
154170-27-1 |
詳細(xì)
|
posaconazole impurity 30 |
泊沙康唑雜質(zhì)30 |
|
詳細(xì)
|
Olmesartan Medoxomil Impurity 23 |
奧美沙坦酯雜質(zhì)23 |
|
詳細(xì)
|
Pitavastatin Calcium Salt |
|
147526-32-7 |
詳細(xì)
|
Pitavastatin IMpurity 22 |
匹伐他汀雜質(zhì)22 |
|
詳細(xì)
|
(Z)-methyl 1-acetyl-3 |
尼達(dá)尼布雜質(zhì)K |
|
詳細(xì)
|
N-Isopropyl Tadalafil |
他達(dá)拉非雜質(zhì) |
171596-30-8 |
詳細(xì)
|
Posaconazole iMpurity 3 |
泊沙康唑雜質(zhì)3 |
|
詳細(xì)
|
Pitavastatin Impurity 3 |
匹伐他汀雜質(zhì)3 |
|
詳細(xì)
|
Posaconazole iMpurity 26 |
泊沙康唑雜質(zhì)26 |
|
詳細(xì)
|
Posaconazole iMpurity 9 |
泊沙康唑雜質(zhì)9 |
|
詳細(xì)
|
Palbociclib Impurity 59 |
帕布昔利布雜質(zhì)59 |
1072-97-5 |
詳細(xì)
|
Obeticholic Acid impurity J |
奧貝膽酸雜質(zhì)J |
|
詳細(xì)
|
Olmesartan Medoxomil Impurity DX;5-(4'-(dibromomethyl)-[1,1'-biphenyl]-2-yl)-1H-tetrazole |
奧美沙坦酯雜質(zhì)DX |
|
詳細(xì)
|
Penfluridol |
五氟利多 |
26864-56-2 |
詳細(xì)
|
Posaconazole iMpurity 2 |
泊沙康唑雜質(zhì)2 |
|
詳細(xì)
|
nifedipine iMpurity 3 |
硝苯地平雜質(zhì)3 |
|
詳細(xì)
|
Olanzapine impurity J;1,1-dimethyl-4-(2-methyl-10Hbenzo[b]thieno[2,3-e][1,4]diazepin-4-yl)piperazin-1-ium iodide |
奧氮平雜質(zhì)J |
|
詳細(xì)
|
posaconazole impurity 10 |
3泊沙康唑雜質(zhì)10 |
|
詳細(xì)
|
(3R,5S,2R,3S)-posaconazole |
泊沙康唑雜質(zhì)20 |
1229428-91-4 |
詳細(xì)
|
Rebamipide Impurity 4 |
瑞巴匹特雜質(zhì)4 |
4876-14-6 |
詳細(xì)
|
Pitavastatin IMpurity 13 |
匹伐他汀雜質(zhì)13 |
|
詳細(xì)
|
Olmesartan Medoxomil Impurity 20;5-(4'-methyl-[1,1'-biphenyl]-2-yl)-1-trityl-1H-tetrazole |
奧美沙坦酯雜質(zhì)20 |
|
詳細(xì)
|
R-Clopidogrel N-Oxide;5-((R)-2-methoxy-2-oxo-1-(o-tolyl)ethyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine 5-oxide |
R-氯吡格雷氮氧化物 |
|
詳細(xì)
|
Palbociclib Impurity 54 |
帕布昔利布雜質(zhì)54 |
153747-97-8 |
詳細(xì)
|
Tadalafil Impurity 20 |
他達(dá)拉非雜質(zhì) |
171596-36-4 |
詳細(xì)
|
Posaconazole iMpurity 7 |
泊沙康唑雜質(zhì)7 |
|
詳細(xì)
|
Pitavastatin Impurity 54 |
匹伐他汀雜質(zhì)54 |
847849-67-6 |
詳細(xì)
|
posaconazole impurity 31 |
泊沙康唑雜質(zhì)31 |
|
詳細(xì)
|
Olmesartan Medoxomil Impurity 24 |
奧美沙坦酯雜質(zhì)24 |
|
詳細(xì)
|
Pivampicillin |
氨芐西林雜質(zhì) |
33817-20-8 |
詳細(xì)
|
Parecoxib Impurity 1 |
帕瑞昔布雜質(zhì)1 |
451-40-1 |
詳細(xì)
|
Nintedanib Impurity L;(E)-methyl 1-acetyl-2-oxo-3-(phenyl(piperidin-1-yl)methylene)indoline-6-carboxylate |
尼達(dá)尼布雜質(zhì)L |
|
詳細(xì)
|
Olmesartan Medoxomil Impurity 17 |
奧美沙坦酯雜質(zhì)17 |
|
詳細(xì)
|
Nintedanib impurity F |
尼達(dá)尼布雜質(zhì)F |
|
詳細(xì)
|
(R)-4-benzyl-3-(4-(2,4-difluorophenyl)pent-4-enoyl)oxazolidin-2-one |
泊沙康唑雜質(zhì)24 |
|
詳細(xì)
|
Posaconazole iMpurity 12 |
泊沙康唑雜質(zhì)12 |
|
詳細(xì)
|
Obeticholic Acid impurity C |
奧貝膽酸雜質(zhì)C |
|
詳細(xì)
|
Intedanib Impurity B |
尼達(dá)尼布雜質(zhì)B |
|
詳細(xì)
|
Intedanib Impurity G |
尼達(dá)尼布雜質(zhì)G |
|
詳細(xì)
|
Pitavastatin Impurity 1 |
匹伐他汀雜質(zhì)1 |
|
詳細(xì)
|
Obeticholic Acid impurity E |
奧貝膽酸雜質(zhì)E |
|
詳細(xì)
|
Posaconazole iMpurity 1 |
泊沙康唑雜質(zhì)1 |
|
詳細(xì)
|
Obeticholic Acid impurity I |
奧貝膽酸雜質(zhì)I |
|
詳細(xì)
|
Nintedanib Impurity H |
尼達(dá)尼布雜質(zhì)H |
|
詳細(xì)
|
Nintedanib Impurity O |
|
334951-61-0 |
詳細(xì)
|
Olmesartan Medoxomil Impurity W |
奧美沙坦酯雜質(zhì)W |
|
詳細(xì)
|
Olmesartan Medoxomil Impurity 18;5-methyl-2-oxo-1,3-dioxol-4-yl 1-((2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-4-(2-methoxypropan-2-yl)-2-propyl-1H-imidazole-5-carboxylate |
奧美沙坦酯雜質(zhì)18 |
|
詳細(xì)
|
Obeticholic Acid impurity G |
奧貝膽酸雜質(zhì)G |
|
詳細(xì)
|
rac Cinacalcet-d3 Hydrochloride;α-(Methyl-d3)-N-[3-[3-(trifluoromethyl)phenyl)propyl]-1-napthalenemethanamine Hydrochloride |
鹽酸西那卡塞-d3 |
1185097-33-9 |
詳細(xì)
|
Palbociclib Impurity 8 |
帕布昔利布雜質(zhì)8 |
827022-31-1 |
詳細(xì)
|
Obeticholic Acid impurity F |
奧貝膽酸雜質(zhì)F |
|
詳細(xì)
|